Suchergebnisse - "Rodden, Layne N"

PubPharm (18)

11

Clinical Evidence for Variegated Silencing in Patients With Friedreich Ataxia

enthalten in: Neurology. Genetics | 2022

von Rodden, L. | Rummey, C. | Dong, Y. | +1

12

DNA methylation in Friedreich ataxia silences expression of frataxin isoform E

enthalten in: Scientific reports | 2022

von Rodden, L. | Gilliam, K. | Lam, C. | +8

13

A non-synonymous single nucleotide polymorphism in SIRT6 predicts neurological severity in Friedreich ataxia

enthalten in: Frontiers in molecular biosciences | 2022

von Rodden, L. | Rummey, C. | Dong, Y. | +20

14

Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia

enthalten in: Frontiers in neuroscience | 2022

von Mercado-Ayón, E. | Warren, N. | Halawani, S. | +8

15

Designing phase II clinical trials in Friedreich ataxia

enthalten in: Expert opinion on emerging drugs | 2021

von Rodden, L. | Lynch, D.

16

Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia

enthalten in: Human molecular genetics | 2021

von Rodden, L. | Chutake, Y. | Gilliam, K. | +9

17

Epigenetic Heterogeneity in Friedreich Ataxia Underlies Variable FXN Reactivation

enthalten in: Frontiers in neuroscience | 2021

von Rodden, L. | Gilliam, K. | Lam, C. | +2

18

Designing phase II clinical trials in Friedreich ataxia

enthalten in: Expert opinion on emerging drugs | 2021

von Rodden, L. | Lynch, D.